Multiple sclerosis, Immunology, Cerebrospinal fluid, Chemokine and Inflammation are his primary areas of study. His Multiple sclerosis research incorporates themes from Genetics, Genome-wide association study, Pathology and Internal medicine, Methylprednisolone. His study in Myelin basic protein extends to Immunology with its themes.
His Cerebrospinal fluid study incorporates themes from Fungal meningitis, Central nervous system disease and Optic neuritis. His Chemokine research focuses on Microglia and how it relates to Monocyte, CD14 and Mononuclear phagocyte system. The various areas that Finn Sellebjerg examines in his Inflammation study include Regulatory T cell, Adoptive cell transfer, CD47 and FOXP3.
His main research concerns Multiple sclerosis, Immunology, Internal medicine, Cerebrospinal fluid and Pathology. His work investigates the relationship between Multiple sclerosis and topics such as Magnetic resonance imaging that intersect with problems in Surgery. Finn Sellebjerg regularly links together related areas like Myelin basic protein in his Immunology studies.
He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Expanded Disability Status Scale and, in certain cases, Physical therapy. His Cerebrospinal fluid study integrates concerns from other disciplines, such as Biomarker, Demyelinating disease, Methylprednisolone and Central nervous system disease. Finn Sellebjerg interconnects Fingolimod and Clinical trial in the investigation of issues within Natalizumab.
Finn Sellebjerg mostly deals with Multiple sclerosis, Internal medicine, Immunology, Cohort and Pediatrics. His Multiple sclerosis research is multidisciplinary, relying on both Antibody, Disease and Cohort study. His study on Discontinuation, Neurofilament light and Relapse rate is often connected to In patient as part of broader study in Internal medicine.
His research on Immunology often connects related areas such as Cerebrospinal fluid. His work focuses on many connections between Cerebrospinal fluid and other disciplines, such as Inflammation, that overlap with his field of interest in Biomarker. Finn Sellebjerg studied Cohort and Odds ratio that intersect with Genetic predisposition and Haplotype.
His scientific interests lie mostly in Multiple sclerosis, Internal medicine, Immunology, Disease and Pathogenesis. His research in Multiple sclerosis intersects with topics in Immune system, Alemtuzumab and Cohort study. Finn Sellebjerg works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Active inflammation, Neurodegeneration and Early phase.
His Immunology study combines topics from a wide range of disciplines, such as Gene expression and Macular degeneration. Clinically isolated syndrome, Demyelinating Disorder, Natural history, Epidemiology and Incidence is closely connected to Pediatrics in his research, which is encompassed under the umbrella topic of Disease. His Pathogenesis course of study focuses on Proinflammatory cytokine and Flow cytometry, CD8, T cell and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
Torben L. Sørensen;Marie Tani;Jakob Jensen;Virginia Pierce.
Journal of Clinical Investigation (1999)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis.
Nature Genetics (2013)
Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement
Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni.
JAMA Neurology (2005)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Bridel C;van Wieringen Wn;Zetterberg H;Tijms Bm.
JAMA Neurology (2019)
Clinical relevance of brain volume measures in multiple sclerosis.
Nicola De Stefano;Laura Airas;Nikolaos Grigoriadis;Heinrich P. Mattle.
CNS Drugs (2014)
Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force.
F. Deisenhammer;A. Bartos;R. Egg;N. E. Gilhus.
European Journal of Neurology (2006)
CCR1+/CCR5+ Mononuclear Phagocytes Accumulate in the Central Nervous System of Patients with Multiple Sclerosis
Corinna Trebst;Torben Lykke Sørensen;Pia Kivisäkk;Martha K. Cathcart.
American Journal of Pathology (2001)
Multiple sclerosis: A study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system
Torben L. Sørensen;Corinna Trebst;Pia Kivisäkk;Karen L. Klaege.
Journal of Neuroimmunology (2002)
Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen;Lars Börnsen;Rikke Ratzer;Fredrik Piehl.
PLOS ONE (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: